Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110372788A details a high-purity chemical synthesis route for gram insulin. This breakthrough offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102180964B reveals a high-yield solid-phase synthesis for Human Relaxin-2. Achieve 74-82% yield with simplified Fmoc strategies for reliable pharmaceutical intermediate supply.
Patent CN115109118A introduces a solid-phase synthesis method for DS-8201 intermediates, offering superior purity and cost reduction for ADC manufacturing.
Novel fragment condensation method for Tesamorelin improves purity and yield. Ideal for pharmaceutical intermediates manufacturing and large-scale production.
Patent CN119080911B reveals modified Gly-AM resin method improving yield and purity for scalable manufacturing. Enhances supply chain reliability for global pharmaceutical partners seeking cost efficiency.
Discover the novel Alloc-protected solid-phase synthesis of Somatostatin KE108. Eliminating hydrogen hazards for safer, scalable pharmaceutical intermediate production.
Patent CN112538103B reveals a safer, hydrogen-free synthesis route for Somatostatin KE108 using Alloc protection, offering significant cost reduction in peptide manufacturing.
Patent CN113801199A details a novel Mitsunobu cyclization for Carbetocin. Discover cost-effective, scalable solid-phase manufacturing solutions for this oxytocin analogue.
Patent CN114230653B reveals a novel fragment coupling method for Chlorotoxin, achieving >99% purity. Discover cost-effective manufacturing strategies for this tumor-targeting peptide intermediate.
Patent CN114685645A details a novel Semaglutide synthesis using NCL and desulfurization, offering improved purity and cost reduction for API manufacturing.
Patent CN103304659B reveals advanced solid-phase synthesis for Liraglutide. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN112300250B details novel Anidulafungin analogs with improved solubility and reduced toxicity. Discover scalable synthesis routes for high-purity antifungal intermediates.
Advanced synthetic route for Daptomycin antibiotic using solid-liquid phase combination. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103880945A details a novel fragment condensation method for Thymalfasin, offering >99% purity and enhanced scalability for reliable pharmaceutical intermediate supply chains.
Patent CN111944037B reveals advanced solid-phase peptide synthesis reducing impurities. Enhances supply chain reliability and cost efficiency for global pharmaceutical manufacturers.
Patent CN111944037B reveals advanced fragment condensation for semaglutide. Enhances purity and yield while enabling cost reduction in API manufacturing for global supply chains.
Patent CN107778351B reveals high-purity octreotide synthesis. Achieve cost reduction in peptide manufacturing with scalable all-solid-phase methods.
Patent CN104497130A reveals a novel 2+6 segment condensation method for Lanreotide, enhancing purity and yield for cost-effective peptide manufacturing supply chains.
Patent CN103214568A details a novel Fmoc solid-phase method using pseudo-proline dipeptides to enhance yield and purity for industrial secretin production.
Patent CN112194708A details a novel Procatide synthesis using FMPB-modified resin and stepwise disulfide bonding, ensuring high purity and yield for reliable supply chains.